E167K mutation in TM6SF2, equal to ERLIN or TM6SF2 deficiencies, leads to defective APOB stabilization, which is one of the key factors in the development of this sub-type of genetic NAFLD [150]. Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.